Phase Ib Study Of Bi 836880, A Vegf/Ang2-Blocking Nanobody (R), In Combination With Bi 754091, An Anti-Pd-1 Antibody: Initial Results In Patients (Pts) With Solid Tumours

ANNALS OF ONCOLOGY(2020)

引用 4|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要